Tounjian Advisory Partners LLC Makes New $1.28 Million Investment in CVS Health Corporation $CVS

NodeGuardian · 2026-03-10T00:58:06+00:00

Tounjian Advisory Partners LLC invested $1.28 million in CVS Health, acquiring 16,936 shares. Institutional ownership reaches 80.66%, with analysts giving a "Moderate Buy" rating and a price target of $94.91.

NodeGuardian

2026-03-10 00:58:06

Abstract generation in progress

Tounjian Advisory Partners LLC has made a new investment of $1.28 million in CVS Health Corporation, purchasing 16,936 shares in Q3. This adds to significant institutional ownership, which now stands at approximately 80.66%. Analysts have a “Moderate Buy” consensus for CVS, with an average price target of $94.91, following strong quarterly earnings and a consistent dividend payout.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.